Assignee
VIGIL NEUROSCIENCE INC
US·0 granted patents·9 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
9 records- 0171US2025326839A1Treatment of diseases related to colony-stimulating factor 1 receptor dysfunction using trem2 agonistsVIGIL NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 0270US2025282866A1Treatment of diseases related to atp-binding cassette transporter 1 dysfunction using trem2 agonistsVIGIL NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 0367US2025042897A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 0460US2022089726A1Treatment of diseases related to colony-stimulating factor 1 receptor dysfunction using trem2 agonistsVIGIL NEUROSCIENCE INC·Filed 2021·Application pending·0 cites
- 0559US2023082623A1Treatment of diseases related to atp-binding cassette transporter 1 dysfunction using trem2 agonistsVIGIL NEUROSCIENCE INC·Filed 2021·Application pending·0 cites
- 0659US2025304580A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 0756US2024309003A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 0854US2024270843A1Trem2 agonist biomarkers and methods of use thereofVIGIL NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 0952US2025019437A1Anti-trem2 antibody and uses thereofVIGIL NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →